The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Chronic immune activation and inflammation as the cause of malignancy
Open accessAbstract
Several chronic infections known to be associated with malignancy have established oncogenic properties. However the existence of chronic inflammatory conditions that do not have an established infective cause and are associated with the development of tumours strongly suggests that the inflammatory process itself provides the prerequisite environment for the development of malignancy. This environment includes upregulation of mediators of the inflammatory response such as cyclo-oxygenase (COX)-2 leading to the production of inflammatory cytokines and prostaglandins which themselves may suppress cell mediated immune responses and promote angiogenesis. These factors may also impact on cell growth and survival signalling pathways resulting in induction of cell proliferation and inhibition of apoptosis. Furthermore, chronic inflammation may lead to the production of reactive oxygen species and metabolites such as malondialdehyde within the affected cells that may in turn induce DNA damage and mutations and, as a result, be carcinogenic. Here it is proposed that the conditions provided by a chronic inflammatory environment are so essential for the progression of the neoplastic process that therapeutic intervention aimed at inhibiting inflammation, reducing angiogenesis and stimulating cell mediated immune responses may have a major role in reducing the incidence of common cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“…available online at http://www.idealibrary.com on http://www.bjcancer.com Cancer arises as a result of a multi-step process leading from the initial benign transformation of cells through to overt invasive, metastatic disease (Lengauer et al, 1998; Raza, 2000; Vogelstein et al, 1988).”
BackgroundVane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 2×
“Recent research has indicated that angiogenesis may play a key role in the development of early neoplastic lesions and subsequent malignancy (Bergers et al, 1999).”
BackgroundMice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 736
Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff, H. J., Saukkonen, K., Anttila, S. L., Karjalainen, A., Vainio, H., & Ristimaki, A. P. (1998) · PubMed · Cited by 717
The Th1–Th2 hypothesis of HIV infection: new insights
Clerici, M., & Shearer, G. M. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90220-8 · Cited by 685
Piccinni, M.-P., Beloni, L., Livi, C., Maggi, E., Scarselli, G., & Romagnani, S. (1998) · Nature Medicine · doi:10.1038/2006 · Cited by 664
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1375 · Cited by 649 · cited 2×
“Macrophage inhibitory factor (MIF) is released during inflammatory states and has recently been shown to repress the transcription activity of p53 and its downstream targets of p21 and bax, thereby having a marked anti-apoptotic effect (Cordon-Cardo and Prives, 1999; Hudson et al, 1999).”
BackgroundHuang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Gabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., & Carbone, D. P. (1999) · PubMed · Cited by 459
Natural history of HLA expression during tumour development
Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., & Stern, P. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90264-l · Cited by 448
Molina, M. A., Sitjà, M., Lemoine, M. G., Frazier, M. L., & Sinicrope, F. A. (1999) · PubMed · Cited by 438
Langman, M. J. S. (2000) · BMJ · doi:10.1136/bmj.320.7250.1642 · Cited by 419
Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus
Jankowski, J. A., Wright, N. A., Meltzer, S. J., Triadafilopoulos, G., Geboes, K., Casson, A. G., Kerr, D., & Young, L. S. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65346-1 · Cited by 412
Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice
Gallucci, R. M., Simeonova, P. P., Matheson, J. M., Kommineni, C., Guriel, J. L., Sugawara, T., & Luster, M. I. (2000) · The FASEB Journal · doi:10.1096/fj.00-0073com · Cited by 405
HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway
Zhou, B. P., Hu, M. C.-T., Miller, S. A., Yu, Z., Xia, W., Lin, S.-Y., & Hung, M.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8027 · Cited by 371
The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis
Gately, S. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026575610124 · Cited by 359
Eliopoulos, A. G., Gallagher, N. J., Blake, S. M. S., Dawson, C. W., & Young, L. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16085 · Cited by 354
Edwards, J. G. (2000) · Thorax · doi:10.1136/thorax.55.9.731 · Cited by 324
Detection of Epstein-Barr Virus in Invasive Breast Cancers
Bonnet, M., Guinebretiere, J.-M., Kremmer, E., Grunewald, V., Benhamou, E., Contesso, G., & Joab, I. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.16.1376 · Cited by 324
Epstein-Barr virus and gastric carcinoma
Takada, K. (2000) · Molecular Pathology · doi:10.1136/mp.53.5.255 · Cited by 323
Hu, P., Margolis, B., Skolnik, E. Y., Lammers, R., Ullrich, A., & Schlessinger, J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.981 · Cited by 321
Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance
Rook, G. A. W., Hernandez-Pando, R., & Lightman, S. L. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90075-2 · Cited by 289
Self-organization, complexity and chaos: The new biology for medicine
Coffey, D. S. (1998) · Nature Medicine · doi:10.1038/nm0898-882 · Cited by 287
Aspirin and reduced risk of esophageal carcinoma
Funkhouser, E. M., & Sharp, G. B. (1995) · Cancer · doi:10.1002/1097-0142(19951001)76:7<1116::aid-cncr2820760703>3.0.co;2-i · Cited by 286
Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation
Béraud, C., Henzel, W. J., & Baeuerle, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.429 · Cited by 281
Murata, H. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00757-6 · Cited by 279
Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E. S., Sasaki, Y., Kawano, S., & Hori, M. (1999) · PubMed · Cited by 270
Simian virus-40 large-T antigen binds p53 in human mesotheliomas
Carbone, M., Rizzo, P., Grimley, P. M., Procopio, A., Mew, D. J. Y., Shridhar, V., De Bartolomeis, A., Esposito, V., Giuliano, M. T., Steinberg, S. M., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-908 · Cited by 257
Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Gunawan, E. S., Takei, Y., Nagano, K., & Hori, M. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.6.g1061 · Cited by 235
Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention
Subbaramaiah, K., Zakim, D., Weksler, B. B., & Dannenberg, A. J. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44170 · Cited by 222
Lymphocyte function in wound healing and following injury
Schäffer, M., & Barbul, A. (1998) · Journal of British Surgery · doi:10.1046/j.1365-2168.1998.00734.x · Cited by 216
Previous Lung Disease and Risk of Lung Cancer among Men and Women Nonsmokers
Mayne, S. T., Buenconsejo, J., & Janerich, D. T. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009722 · Cited by 216
Non-steroidal anti-inflammatory drugs and bladder cancer prevention
Castelao, J. E., Yuan, J.-M., Gago-Dominguez, M., Yu, M. C., & Ross, R. K. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1106 · Cited by 214
De Luca, A., Baldi, A., Esposito, V., Howard, C. M., Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-913 · Cited by 211
Ovarian Cell Differentiation: A Cascade of Multiple Hormones, Cellular Signals, and Regulated Genes
CLEMENS, J. W., JAQUELINE, K. M., ALLISTON, T., RICHARDS, J. S., FITZPATRICK, S. L., & SIROIS, J. (1995) · Proceedings of the 1993 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571150-0.50014-7 · Cited by 207
Immune evasion of tumor cells using membrane-bound complement regulatory proteins
Gorter, A., & Meri, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01537-6 · Cited by 206
O'Byrne, K. J., Dalgleish, A. G., Browning, M. J., Steward, W. P., & Harris, A. L. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00241-5 · Cited by 206
Self-citationKitagawa, N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6742 · Cited by 202
Cox, G., Jones, J. L., & O'Byrne, K. J. (2000) · PubMed · Cited by 197
Self-citationDifferences in angiogenic potential of classically vs alternatively activated macrophages
Kodelja, V., Müller, C., Tenorio, S., Schebesch, C., Orfanos, C. E., & Goerdt, S. (1997) · Immunobiology · doi:10.1016/s0171-2985(97)80080-0 · Cited by 186
Gjertsen, M. K., Bjørheim, J., Saeterdal, I., Myklebust, J., & Gaudernack, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970904)72:5<784::aid-ijc14>3.0.co;2-9 · Cited by 161
At the Crossroads of Inflammation and Tumorigenesis
Cordon-Cardo, C., & Prives, C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1367 · Cited by 160
Aspirin and risk for gastric cancer: a population-based case–control study in Sweden
Akre, K., Ekström, A. M., Signorello, L. B., Hansson, L.-E., & Nyrén, O. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1702 · Cited by 160
Th1 Cytokine Patterns in Cervical Human Papillomavirus Infection
Scott, M. E., Stites, D. P., & Moscicki, A. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.5.751-755.1999 · Cited by 138
Horikawa, T., Yoshizaki, T., Sheen, T., Lee, S.-Y., & Furukawa, M. (2000) · Cancer · Cited by 133
Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes.
Ganss, R., & Hanahan, D. (1998) · PubMed · Cited by 132
Ultraviolet B (UVB)-Induced COX-2 Expression in Murine Skin: An Immunohistochemical Study
Athar, M., An, K. P., Morel, K. D., Kim, A. L., Aszterbaum, M., Longley, J. B., Epstein, E. H., & Bickers, D. R. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4201 · Cited by 132
CANCER RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Lewis, J. D., Deren, J. J., & Lichtenstein, G. R. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70065-0 · Cited by 132
Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice
Duperron, C. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.1001 · Cited by 130
Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro
Yang, T., Schnermann, J. B., & Briggs, J. P. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.1.f1 · Cited by 124
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia
Marzo, A. M. D., Coffey, D. S., & Nelson, W. G. (1999) · Urology · doi:10.1016/s0090-4295(98)00536-6 · Cited by 118
Huang, Y., Sheen, T., Chen, C. L., Lu, J., Chang, Y., Chen, J. Y., & Tsai, C.-H. A. (1999) · PubMed · Cited by 116
Al‐Saleh, W., Giannini, S. L., Jacobs, N., Moutschen, M. P., Doyen, J., Boniver, J., & Delvenne, P. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199803)184:3<283::aid-path25>3.0.co;2-k · Cited by 115
Dalgleish, A. G. (1991) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072457 · Cited by 115
Self-citationBontkes, H. J., de Gruijl, T. D., Walboomers, J. M. M., Schiller, J. T., Dillner, J., Helmerhorst, T. J. M., Verheijen, R. H. M., Scheper, R. J., & Meijer, C. J. L. M. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-2-409 · Cited by 114
Tomozawa, S., Nagawa, H., Tsuno, N. H., Hatano, K., Osada, T., Kitayama, J., Sunami, E., Nita, M. E., Ishihara, S., Yano, H., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6694262 · Cited by 112
Tsuji, S., Kawano, S., Sawaoka, H., Takei, Y., Kobayashi, I., Nagano, K., Fusamoto, H., & Kamada, T. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90095-2 · Cited by 110
Irani, J., Goujon, J., Ragni, E., Peyrat, L., Hubert, J., Saint, F., & Mottet, N. (1999) · Urology · doi:10.1016/s0090-4295(99)00152-1 · Cited by 107
Significant Roles of Inducible Cyclooxygenase (COX)-2 in Angiogenesis in Rat Sponge Implants
Majima, M., Isono, M., Ikeda, Y., Hayashi, I., Hatanaka, K., Harada, Y., Katsumata, O., Yamashina, S., Katori, M., & Yamamoto, S. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.75.105 · Cited by 105
Popolo, A. D., Memoli, A., Apicella, A., Tuccillo, C., Palma, A. M. D., Ricchi, P., Acquaviva, A. M., & Zarrilli, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203952 · Cited by 105
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7
Höpfl, R. M., Heim, K., Christensen, N. D., Zumbach, K., Wieland, U., Volgger, B., Widschwendter, A., Haimbuchner, S., Müller‐Holzner, E., Pawlita, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03315-8 · Cited by 102
Role of schistosomiasis in human bladder cancer
Badawi, A. F., Mostafa, M. H., Probert, A. J., et al. (1995) · European Journal of Cancer Prevention · doi:10.1097/00008469-199502000-00004 · Cited by 99
Inhibition of Cyclooxygenase‐2 Expression: An Approach to Preventing Head and Neck Cancer
MESTRE, J. R., Chan, G. G., Zhang, F., Yang, E. K., Sacks, P. G., Boyle, J. O., Shah, J. P., Edelstein, D. R., Subbaramaiah, K., & Dannenberg, A. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08724.x · Cited by 99
Heriot, A. G., Marriott, J. B., Cookson, S., Kumar, D., & Dalgleish, A. G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1034 · Cited by 98
Self-citationJanssen-Heininger, Y. M. W., Driscoll, K. E., Howard, B. W., Quinlan, T. R., Treadwell, M. D., Barchowsky, A., & Mossman, B. T. (1997) · Europe PMC (PubMed Central) · Cited by 97
Does the HIV envelope induce a chronic graft-versus-host-like disease?
Habeshaw, J. A., Hounsell, E. F., & Dalgleish, A. G. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90155-z · Cited by 88
Self-citationAnalysis of IFN- -Induced Cell Cycle Arrest and Cell Death in Hepatocytes
Kano, A., Watanabe, Y., Takeda, N., & Aizawa, T. S.-I. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021639 · Cited by 87
Yeung, M. C., & Lau, A. S. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25198 · Cited by 84
Péus, D., Vasa, R. A., Meves, A., Beyerle, A., & Pittelkow, M. R. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720135uiegfr2.0.co2 · Cited by 84
McGinty, A., Chang, Y. E., Sorokin, A., Bokemeyer, D., & Dunn, M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12095 · Cited by 83
Germ cell tumors of the testis overexpress wild-type p53.
Guillou, L., Estreicher, A., Chaubert, P., HURLIMANN, J., Kurt, A.-M., Metthez, G., Iggo, R. D., Gray, A., Jichlinski, P., Leisinger, H., et al. (1996) · PubMed Central · Cited by 82
Helicobacter pylori: from the benign to the malignant
Williams, M. P., & Pounder, R. E. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00657-7 · Cited by 82
Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Murata, H., & Hori, M. (1998) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199800001-00009 · Cited by 80
Takahashi, Y., Kawahara, F., Noguchi, M., Miwa, K., Sato, H., Seiki, M., Inoue, H., Tanabe, T., & Yoshimoto, T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01328-9 · Cited by 78
Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors
Koshiba, T., Hosotani, R., Miyamoto, Y., Wada, M., Lee, J.-U., Fujimoto, K., Tsuji, S., Nakajima, S., Doi, R., & Imamura, M. (1999) · International Journal of Gastrointestinal Cancer · doi:10.1007/bf02781733 · Cited by 77
Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications
Strand, S., & Galle, P. R. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01191-x · Cited by 77
Yao, R. (2000) · Experimental Lung Research · doi:10.1080/01902140150216783 · Cited by 73
The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer
Uotila, P. J. (1996) · Cancer Immunology Immunotherapy · doi:10.1007/bf03354243 · Cited by 71
El‐Bayoumy, K., Iatropoulos, M. J., Amin, S., et al. (1999) · PubMed · Cited by 66
Faux, S. P., & Howden, P. J. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51127 · Cited by 66
Maraveyas, A., Baban, B., Kennard, D., Rook, G. A. W., Westby, M., Grange, J. M., Lydyard, P. M., Stanford, J. L., Jones, M., Selby, P., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008307821189 · Cited by 66
Self-citationLala, P. K., Al-Mutter, N., & Orucevic, A. (1997) · International Journal of Cancer · Cited by 65
Clavel, C., Masure, M., Levert, M., Putaud, I., Mangeonjean, C., Lorenzato, M., Nazeyrollas, P., Gabriel, R., Quéreux, C., & Birembaut, P. L. (2000) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200009000-00004 · Cited by 65
Watanabe, M., McCormick, K. L., Völker, K., Ortaldo, J. R., Wigginton, J. M., Brunda, M. J., Wiltrout, R. H., & Fogler, W. E. (1997) · Europe PMC (PubMed Central) · Cited by 62
Keay, S. K., Zhang, C.-O., Baldwin, B. R., & Alexander, R. B. (1999) · Urology · doi:10.1016/s0090-4295(98)00553-6 · Cited by 61
Faux, S. P., Houghton, C. E., Hubbard, A., & Patrick, G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.12.2275 · Cited by 60
Natural history of chronic hepatitis B and C
Imperial, J. C. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01903.x · Cited by 57
Pettit, S. J., Seymour, K., O'Flaherty, E., & Kirby, J. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1206 · Cited by 50
Westby, M., Marriott, J. B., Guckian, M., Cookson, S., Hay, P., & Dalgleish, A. G. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00505.x · Cited by 50
Self-citationJacobs, N., Giannini, S. L., Doyen, J., Baptista, A., Moutschen, M. P., Boniver, J., & Delvenne, P. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00437.x · Cited by 49
Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer.
Konturek, P. C., Hartwich, A., Żuchowicz, M., et al. (2000) · PubMed · Cited by 47
Esophageal Cancers: Changing Character, Increasing Incidence
McCann, J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.497 · Cited by 46
Augmented myocardial ischaemia by nicotine – Mechanisms and their possible significance
Schrör, K., Zimmermann, K. C., & Tannhäuser, R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702061 · Cited by 44
MOLECULAR PATHOBIOLOGY AND IMMUNOLOGY OF MALIGNANT MESOTHELIOMA
Bielefeldt‐Ohmann, H., Jarnicki, A., & FITZPATRICK, D. R. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199604)178:4<369::aid-path460>3.0.co;2-8 · Cited by 43
Buanec, H. L., D'Anna, R., Lachgar, A., Zagury, J., Bernard, J., Ittelé, D., d’Alessio, P., Hallez, S., Giannouli, C., Burny, A., et al. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80122-x · Cited by 41
Hildesheim, A., Schiffman, M. H., Tsukui, T., et al. (1997) · PubMed · Cited by 40
Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.
Melief, C. J. M., & Kast, W. M. (1991) · PubMed · Cited by 33
Saareks, V., Mucha, I., Sievi, E., Vapaatalo, H., & Riutta, A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00384-7 · Cited by 31
Aspirin and the prevention of colorectal cancer: A review of the evidence
Paganini‐Hill, A. (1994) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980100303 · Cited by 30
Wallenius, V., Wallenius, K., & Jansson, J. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80130-0 · Cited by 27
Faux, S. P., & Howden, P. J. (1997) · Environmental Health Perspectives · doi:10.2307/3433520 · Cited by 16
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
Cited by
NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials
Singh, N., Manshian, B., Jenkins, G. J. S., Griffiths, S. M., Williams, P. M., Maffeis, T. G. G., Wright, C. J., & Doak, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.009 · Cited by 1,184
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Inflammation and necrosis promote tumour growth
Vakkila, J., & Lotze, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1415 · Cited by 690
The Potential Benefits of Red Beetroot Supplementation in Health and Disease
Clifford, T., Howatson, G., West, D., & Stevenson, E. (2015) · Nutrients · doi:10.3390/nu7042801 · Cited by 635
“Chronic inflammation is often implicated in the onset and progression of several clinical disorders such as obesity, liver disease, cancer and heart disease [69,74,75].”
Background
Metadata
- Authors
- O'Byrne, K. J., & Dalgleish, A. G.
- Venue
- British Journal of Cancer
- Published
- 2001-08
- Volume
- 85
- Issue
- 4
- Pages
- 473-483
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2132218438
- Cited by
- 543
- References
- 120
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.